Scarica l'app Stockscreener
3.75
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EVH Giù?
Forum
Previsione
Precedente Chiudi:
$3.75
Aprire:
$3.79
Volume 24 ore:
1.51M
Relative Volume:
0.49
Capitalizzazione di mercato:
$427.57M
Reddito:
$1.88B
Utile/perdita netta:
$-534.51M
Rapporto P/E:
-0.7284
EPS:
-5.1483
Flusso di cassa netto:
$4.76M
1 W Prestazione:
+19.81%
1M Prestazione:
+68.92%
6M Prestazione:
-43.78%
1 anno Prestazione:
-62.31%
Intervallo 1D:
$3.635
$3.84
Intervallo di 1 settimana:
$3.08
$3.84
Portata 52W:
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Nome
Evolent Health Inc
Settore
Industria
Telefono
571-389-6000
Indirizzo
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.75 | 427.57M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
171.60 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.58 | 10.16B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
55.00 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.40 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.98 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-13 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-11-08 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Aggiornamento | Truist | Hold → Buy |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-01 | Iniziato | Oppenheimer | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-10-16 | Iniziato | UBS | Buy |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2022-11-01 | Iniziato | Truist | Hold |
| 2022-07-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2021-11-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Ripresa | JP Morgan | Neutral |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-07-06 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Downgrade | Goldman | Buy → Neutral |
| 2020-06-02 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Ripresa | Leerink Partners | Outperform |
| 2018-06-04 | Iniziato | Piper Jaffray | Overweight |
| 2018-04-24 | Ripresa | JP Morgan | Neutral |
| 2017-09-20 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Iniziato | Robert W. Baird | Outperform |
| 2017-03-14 | Iniziato | Oppenheimer | Outperform |
| 2017-01-13 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Ripresa | JP Morgan | Overweight |
| 2016-08-05 | Reiterato | FBR Capital | Outperform |
| 2016-07-26 | Iniziato | Jefferies | Buy |
| 2016-07-13 | Reiterato | FBR Capital | Outperform |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
| 2016-01-06 | Iniziato | Canaccord Genuity | Buy |
| 2015-06-30 | Iniziato | Goldman | Buy |
| 2015-06-30 | Iniziato | JP Morgan | Overweight |
| 2015-06-30 | Iniziato | Leerink Partners | Outperform |
| 2015-06-30 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Evolent Health Inc Borsa (EVH) Ultime notizie
MSN Money - MSN
Evolent Health (EVH) price target decreased by 32.38% to 6.01 - MSN
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Sahm
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves - MSN
Evolent Health Stock Rises on Q4 Earnings Beat and Strong 2026 Revenue Forecast - IndexBox
Why Evolent Health (EVH) Stock Is Up Today - Yahoo Finance
Evolent Health : 2026 Broadridge Broker Notice - marketscreener.com
Executive pay and board refresh in Evolent Health (NYSE: EVH) 2026 proxy - Stock Titan
[ARS] Evolent Health, Inc. SEC Filing - Stock Titan
Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4 - Yahoo Finance
Evolent Health | DEFA14A: Others - Moomoo
EVH (Evolent Health Inc) beats Q4 2025 EPS forecasts, but shares drop five percent amid mixed investor sentiment.Margin Improvement - UBND thành phố Hải Phòng
Is Evolent Health (EVH) stock forming a breakout today (Risk Aversion) 2026-04-22Real-time Trade Ideas - UBND thành phố Hải Phòng
Evolent Health (EVH) Stock Chart | Q4 2025: Profit SurprisesCommunity Exit Signals - Cổng thông tin điện tử Tỉnh Sơn La
EVH Stock Grinds Higher As Traders Watch Momentum - StocksToTrade
Evolent Health Inc stock (US30050B1017): Why Google Discover changes matter more now - AD HOC NEWS
Evolent Health Inc stock (US30050B1017): Why healthcare tech execution is suddenly worth a closer lo - AD HOC NEWS
EVH Earnings History & Surprises | EPS & Revenue Results | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
RBC Capital Maintains Evolent Health(EVH.US) With Hold Rating, Maintains Target Price $3 - Moomoo
Evolent Health Receives 'Moderate Buy' Consensus from Analysts - National Today
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
CEO Moves: What is Evolent Health Incs 5 year growth outlookGlobal Markets & High Win Rate Trade Tips - baoquankhu1.vn
Inflation Data: Whats next for Evolent Health Inc stockWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Are short sellers targeting Evolent Health (EVH) Stock | Price at $2.40, Up 3.22%Sector Rotation - Xã Vĩnh Công
Is Evolent Health (EVH) Stock Testing Resistance | Price at $2.40, Down 1.64%Market Analysis - Xã Vĩnh Công
Tudor Investment Corp Boosts Stake in Evolent Health - National Today
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 - Sahm
Evolent To Release First Quarter 2026 Financial Results on Thurs - GuruFocus
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know - Yahoo Finance
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 – Company Announcement - Financial Times
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Trend Review: Whats Evolent Health Incs historical return2026 PreEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Context Capital Management, LLC's Evolent Health Inc(EVH) Holding History - GuruFocus
EVH Stock Analysis: Evolent Health Inc Healthcare Play at 2.25 With Mild Daily Gain - UBND thành phố Hải Phòng
Evolent Health, Inc. (9EH.F) stock price, news, quote and history - Yahoo Finance Singapore
Chart Watch: Is Evolent Health Inc stock a top performer YTD2026 Big Picture & Safe Capital Allocation Plans - baoquankhu1.vn
What is Evolent Health Incs 5 year growth outlookMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Can Evolent Health Inc continue delivering strong returns2026 Trends & Community Trade Idea Sharing - baoquankhu1.vn
Smart Money: Can Evolent Health Inc continue delivering strong returnsWeekly Investment Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Market Sell-Off: Stocks Drop on Geopolitical Uncertainty and Oil Price FearsNews and Statistics - IndexBox
Evolent Health Receives $6.04 Average Price Target from Analysts - National Today
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance
Evolent Health Inc Azioni (EVH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.72%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):